Henan Lingrui Pharmaceutical Co Ltd (600285) — Tangible Net Worth Ratio

Latest as of March 2026: 90.9%

Henan Lingrui Pharmaceutical Co Ltd (600285) has a Tangible Net Worth Ratio of 90.9% as of March 2026. This metric is calculated by deducting intangible assets (CN¥336.93 Million) from net assets (CN¥3.69 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Henan Lingrui Pharmaceutical Co Ltd (600285) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Tangible NW Ratio

90.9%
Tangible equity / total equity

Net Assets (Equity)

CN¥3.69 Billion
CNY

Intangible Assets

CN¥336.93 Million
Goodwill, patents, brand value

Total Assets

CN¥5.97 Billion
CNY

Henan Lingrui Pharmaceutical Co Ltd Tangible Net Worth Ratio (1997–2025)

This chart shows how Henan Lingrui Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 29 annual periods from 1997 to 2025. As of March 2026, the ratio stands at 90.9%, reflecting net assets of CN¥3.69 Billion with intangible assets of CN¥336.93 Million CNY. See Henan Lingrui Pharmaceutical Co Ltd (600285) liquidity interval to measure how many days the company can operate on defensive assets alone.

Annual Tangible Net Worth Ratio for Henan Lingrui Pharmaceutical Co Ltd (1997–2025)

The table below presents the year-by-year Tangible Net Worth Ratio for Henan Lingrui Pharmaceutical Co Ltd from 1997 to 2025, covering 29 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see 600285 market cap.

Year Tangible NW Ratio Net Assets (CNY) Intangible Assets Total Assets Change (pp)
2025 90.0% CN¥3.44 Billion CN¥343.17 Million CN¥5.64 Billion ▼ -3.2 pp
2024 93.2% CN¥3.08 Billion CN¥209.15 Million CN¥5.02 Billion ▲ +1.4 pp
2023 91.8% CN¥2.80 Billion CN¥229.84 Million CN¥4.77 Billion ▲ +1.2 pp
2022 90.5% CN¥2.56 Billion CN¥241.87 Million CN¥4.34 Billion ▲ +3.1 pp
2021 87.5% CN¥2.29 Billion CN¥286.35 Million CN¥3.79 Billion ▼ -0.3 pp
2020 87.8% CN¥2.32 Billion CN¥282.85 Million CN¥3.46 Billion ▲ +1.5 pp
2019 86.4% CN¥2.22 Billion CN¥302.76 Million CN¥3.32 Billion ▲ +1.2 pp
2018 85.2% CN¥2.09 Billion CN¥309.97 Million CN¥3.11 Billion ▼ -0.3 pp
2017 85.5% CN¥2.20 Billion CN¥319.41 Million CN¥3.31 Billion ▼ -5.9 pp
2016 91.4% CN¥2.11 Billion CN¥182.45 Million CN¥2.98 Billion ▲ +1.9 pp
2015 89.5% CN¥1.72 Billion CN¥181.52 Million CN¥2.71 Billion ▲ +0.2 pp
2014 89.3% CN¥1.56 Billion CN¥167.25 Million CN¥2.47 Billion ▲ +7.9 pp
2013 81.4% CN¥984.89 Million CN¥183.13 Million CN¥1.65 Billion ▼ -2.7 pp
2012 84.1% CN¥696.97 Million CN¥110.68 Million CN¥1.29 Billion ▼ -1.3 pp
2011 85.5% CN¥684.01 Million CN¥99.47 Million CN¥1.21 Billion ▼ -2.0 pp
2010 87.5% CN¥709.69 Million CN¥88.81 Million CN¥1.20 Billion ▼ -2.1 pp
2009 89.6% CN¥645.69 Million CN¥67.31 Million CN¥1.02 Billion ▲ +0.4 pp
2008 89.2% CN¥549.72 Million CN¥59.41 Million CN¥968.27 Million ▼ -0.8 pp
2007 90.0% CN¥579.24 Million CN¥57.71 Million CN¥942.55 Million ▲ +3.0 pp
2006 87.0% CN¥486.67 Million CN¥63.16 Million CN¥878.69 Million ▼ -0.6 pp
2005 87.7% CN¥479.80 Million CN¥59.22 Million CN¥872.24 Million ▼ -1.4 pp
2004 89.1% CN¥469.45 Million CN¥51.36 Million CN¥828.81 Million ▼ -0.5 pp
2003 89.5% CN¥451.69 Million CN¥47.23 Million CN¥741.34 Million ▼ -7.6 pp
2002 97.1% CN¥416.74 Million CN¥11.99 Million CN¥697.75 Million ▲ +0.1 pp
2001 97.1% CN¥401.79 Million CN¥11.80 Million CN¥560.38 Million ▲ +0.4 pp
2000 96.7% CN¥408.46 Million CN¥13.60 Million CN¥514.79 Million ▲ +14.5 pp
1999 82.2% CN¥62.08 Million CN¥11.06 Million CN¥175.02 Million ▲ +1.9 pp
1998 80.2% CN¥49.85 Million CN¥9.85 Million CN¥125.63 Million ▼ -1.0 pp
1997 81.3% CN¥33.98 Million CN¥6.36 Million CN¥89.69 Million
pp = percentage points